GLAUCOMA MEDS

EyeWorld Magazine: August�2006

This article explains what we all probably already know. 40% of patients on a prostaglandin analogue will need adjunctive therapy, and that a topical carbonic anhydrase inhibitor is more effective than an alpha-agonist (brimonodine or Alphagan-P) as an adjunct. Also brimonodine's effect wears off over time and does not display as flat a diurnal curve as Azopt (or Trusopt).

Comments

  1. Kevin,
    Ironically, the Allergan rep. just showed me a report yesterday concluding that Alphagan-P is the best adjunctive therapy for glaucoma. I forget which source it was from.
    Sometimes it's hard to know which way to go when there are conflicting studies!

    ReplyDelete

Post a Comment

Leave a Comment or Question:

Popular posts from this blog

IMPLANTABLE COLLAMER LENS APPEARS BETTER THAN LASIK OR PRK FOR MODERATE TO HIGH MYOPIC PATIENTS

Keratoconus and Inflammatory Skin Conditions

RINSING YOUR CONTACT LENS CASE IS NOT ENOUGH